Anna Honko, PhD

Research Associate Professor, Virology, Immunology & Microbiology

Anna Honko
617.358.2900
honko@bu.edu
View full profile at BUMC

Biography

Anna Honko, PhD recently joined Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) as a Research Associate Professor. In the Nonclinical Studies Unit, she’ll be directing well-documented, Animal Rule and GLP studies to advance anti-viral medical countermeasure development. Dr. Honko’s background is in immunology and vaccine development, with a later emphasis in biothreat and emerging infectious diseases. She has a focus on regulated studies as well a passion for radiotelemetry monitoring.

Other Positions

  • Faculty, National Emerging Infectious Disease Lab, Boston University

Websites

Education

  • Wake Forest University, PhD
  • Clemson University, BS

Publications

  • Published on 4/20/2023

    Pittman PR, Martin JW, Kingebeni PM, Tamfum JM, Mwema G, Wan Q, Ewala P, Alonga J, Bilulu G, Reynolds MG, Quinn X, Norris S, Townsend MB, Satheshkumar PS, Wadding J, Soltis B, Honko A, Güereña FB, Korman L, Patterson K, Schwartz DA, Huggins JW. Clinical characterization and placental pathology of mpox infection in hospitalized patients in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2023 Apr; 17(4):e0010384. PMID: 37079637.

    Read at: PubMed
  • Published on 1/21/2023

    Chang MR, Ke H, Losada Miguéns L, Coherd C, Nguyen K, Kamkaew M, Johnson R, Storm N, Honko A, Zhu Q, Griffiths A, Marasco WA. The variable conversion of neutralizing anti-SARS-CoV-2 single-chain antibodies to IgG provides insight into RBD epitope accessibility. Protein Eng Des Sel. 2023 Jan 21; 36. PMID: 37561410.

    Read at: PubMed
  • Published on 12/14/2022

    Hunegnaw R, Honko AN, Wang L, Carr D, Murray T, Shi W, Nguyen L, Storm N, Dulan CNM, Foulds KE, Agans KN, Cross RW, Geisbert JB, Cheng C, Ploquin A, Stanley DA, Geisbert TW, Nabel GJ, Sullivan NJ. A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. Sci Transl Med. 2022 Dec 14; 14(675):eabq6364. PMID: 36516269.

    Read at: PubMed
  • Published on 10/13/2022

    Cross RW, Longini IM, Becker S, Bok K, Boucher D, Carroll MW, Díaz JV, Dowling WE, Draghia-Akli R, Duworko JT, Dye JM, Egan MA, Fast P, Finan A, Finch C, Fleming TR, Fusco J, Geisbert TW, Griffiths A, Günther S, Hensley LE, Honko A, Hunegnaw R, Jakubik J, Ledgerwood J, Luhn K, Matassov D, Meshulam J, Nelson EV, Parks CL, Rustomjee R, Safronetz D, Schwartz LM, Smith D, Smock P, Sow Y, Spiropoulou CF, Sullivan NJ, Warfield KL, Wolfe D, Woolsey C, Zahn R, Henao-Restrepo AM, Muñoz-Fontela C, Marzi A. An introduction to the Marburg virus vaccine consortium, MARVAC. PLoS Pathog. 2022 Oct; 18(10):e1010805. PMID: 36227853.

    Read at: PubMed
  • Published on 10/3/2022

    Chang MR, Tomasovic L, Kuzmina NA, Ronk AJ, Byrne PO, Johnson R, Storm N, Olmedillas E, Hou YJ, Schäfer A, Leist SR, Tse LV, Ke H, Coherd C, Nguyen K, Kamkaew M, Honko A, Zhu Q, Alter G, Saphire EO, McLellan JS, Griffiths A, Baric RS, Bukreyev A, Marasco WA. IgG-like bispecific antibodies with potent and synergistic neutralization against circulating SARS-CoV-2 variants of concern. Nat Commun. 2022 Oct 03; 13(1):5814. PMID: 36192374.

    Read at: PubMed
  • Published on 9/9/2022

    Nikitin PA, DiMuzio JM, Dowling JP, Patel NB, Bingaman-Steele JL, Heimbach BC, Henriquez N, Nicolescu C, Polley A, Sikorski EL, Howanski RJ, Nath M, Shukla H, Scheaffer SM, Finn JP, Liang LF, Smith T, Storm N, McKay LGA, Johnson RI, Malsick LE, Honko AN, Griffiths A, Diamond MS, Sarma P, Geising DH, Morin MJ, Robinson MK. IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2. Sci Immunol. 2022 Sep 09; 7(75):eabl9943. PMID: 35771946.

    Read at: PubMed
  • Published on 3/23/2022

    Das Adhikari U, Eng G, Farcasanu M, Avena LE, Choudhary MC, Triant VA, Flagg M, Schiff AE, Gomez I, Froehle LM, Diefenbach TJ, Ronsard L, Lingwood D, Lee GC, Rabi SA, Erstad D, Velmahos G, Li JZ, Hodin R, Stone JR, Honko AN, Griffiths A, Yilmaz ÖH, Kwon DS. Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival. Clin Infect Dis. 2022 03 23; 74(6):1081-1084. PMID: 34245255.

    Read at: PubMed
  • Published on 2/10/2022

    Cline C, Bell TM, Facemire P, Zeng X, Briese T, Lipkin WI, Shamblin JD, Esham HL, Donnelly GC, Johnson JC, Hensley LE, Honko AN, Johnston SC. Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route. PLoS One. 2022; 17(2):e0263834. PMID: 35143571.

    Read at: PubMed
  • Published on 11/17/2021

    Downs I, Johnson JC, Rossi F, Dyer D, Saunders DL, Twenhafel NA, Esham HL, Pratt WD, Trefry J, Zumbrun E, Facemire PR, Johnston SC, Tompkins EL, Jansen NK, Honko A, Cardile AP. Natural History of Aerosol-Induced Ebola Virus Disease in Rhesus Macaques. Viruses. 2021 11 17; 13(11). PMID: 34835103.

    Read at: PubMed
  • Published on 10/14/2021

    Ai X, Wang D, Honko A, Duan Y, Gavrish I, Fang RH, Griffiths A, Gao W, Zhang L. Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition. J Am Chem Soc. 2021 10 27; 143(42):17615-17621. PMID: 34647745.

    Read at: PubMed

View 66 more publications: View full profile at BUMC

View all profiles